Infectious Disease and Basic Microbiological Mechanisms
Project Number2T32AI007061-46
Former Number5T32AI007061-45
Contact PI/Project LeaderGOLDBERG, MARCIA B
Awardee OrganizationMASSACHUSETTS GENERAL HOSPITAL
Description
Abstract Text
Infectious diseases and microbiology continue to be areas of pivotal importance in health care research.
Infection remains a major cause of mortality worldwide and poses serious problems of both individual and
public health concern in the United States. New pathogens have emerged, including some (COVID-19, Zika)
with catastrophic impact worldwide. Antibiotic resistance continues to occur at an alarming rate among all
classes of mammalian pathogens. Diseases once thought to be near eradication - for example, tuberculosis,
cholera, and rheumatic fever—have rebounded with renewed intensity. Currently in its 45th year, the Infectious
Disease and Basic Microbiological Mechanisms training program maintains as its primary goal the training of
scientists who have a career goal of solving medically relevant problems and who elect rigorous laboratory or
translational training in any of the Harvard adult infectious disease programs or other institutions participating
in this program. Over the past 45 years, the program has successfully trained leaders in academic medicine
and investigators who have made important contributions to the field.
In this competing renewal application, we propose an additional five years of funding. We request six
postdoctoral trainee slots per year. We will use these slots to provide support directly to selected infectious
disease physician fellows (M.D. and M.D.-Ph.D.) during mentored research, and to also provide support to
selected Ph.D. trainees in Harvard Medical School infectious disease and microbiology laboratories focused on
areas that have significant clinical relevance, so as to support the rich research training environment for
physician-scientists within these laboratories and to provide these Ph.D. trainees intensive exposure to
medically-trained clinically-active researchers. Training will include a minimum of two years of mentored
research with hands-on in-laboratory training, appropriate advanced non-degree-granting post-graduate
coursework, attendance and participation of trainees at regular meetings and seminars of direct relevance to
infectious disease and microbiology research, including an annual training program retreat, and instruction in
the preparation of competitive proposals for funding, with a particular emphasis on applications for K and other
career development awards, including foundation awards. The specific aims are as follows:
1. To acquire sufficient training in basic laboratory or translational techniques and approaches to conduct
effective cutting-edge research into relevant infectious disease problems;
2. To foster the creation of impactful scientific contributions by means of strong and longitudinal
mentorship by program faculty; and
3. To develop a primary research focus and a broad understanding of infectious diseases and
microbiology, so as to both enable novel interdisciplinary research and foster independence.
Public Health Relevance Statement
The Infectious Disease and Basic Microbiological Mechanisms training program continues to train postdoctoral
trainees as independent physician scientists (M.D. and M.D.-Ph.D.) and Ph.D. scientists able to recognize and
answer clinically relevant questions in the fields of infectious diseases and microbiology. This training program
is especially important now, as we witness the emergence of new infectious diseases and global pandemics,
the continued challenges of illnesses due to antibiotic-resistant pathogens, and the development of
revolutionary scientific technologies and approaches that have the potential to address these and other issues
in the field.
National Institute of Allergy and Infectious Diseases
CFDA Code
855
DUNS Number
073130411
UEI
FLJ7DQKLL226
Project Start Date
01-July-1976
Project End Date
31-May-2029
Budget Start Date
11-June-2024
Budget End Date
31-May-2025
Project Funding Information for 2024
Total Funding
$519,785
Direct Costs
$551,136
Indirect Costs
$40,971
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Allergy and Infectious Diseases
$519,785
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 2T32AI007061-46
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 2T32AI007061-46
Patents
No Patents information available for 2T32AI007061-46
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 2T32AI007061-46
Clinical Studies
No Clinical Studies information available for 2T32AI007061-46
News and More
Related News Releases
No news release information available for 2T32AI007061-46
History
No Historical information available for 2T32AI007061-46
Similar Projects
No Similar Projects information available for 2T32AI007061-46